MarketInOut Stock Screener Log In | Sign Up

First Tracks Biotherapeutics Inc

IEX • Healthcare • Biotechnology • Quote as of 11/10/2026 15:59
First Tracks Biotherapeutics Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeIEX
Market Capitalization2,090.6 mln
Float35.85 mln
Earnings Date11/03/2026

1-Year Forecast

74.75
Exceptional upside

Relative Strength

94 / 100
Top performer

Debt / Equity

0.03
Debt-free

ROE

-59.88
Deeply negative

ROA

-53.66
Deeply negative

Business Description

First Tracks Biotherapeutics is a clinical-stage company based in San Diego, California, working to develop treatments for autoimmune and inflammatory diseases. The company has three drug candidates in its pipeline, each designed to reduce harmful immune activity through distinct biological pathways. Founded in 2019 and formerly known as Biopharma Co. Inc., the company changed its name in February 2026.

Key Fundamentals

EPS-4.71
ROE-59.88
ROIC-1,334
ROA-53.66
EBITDA, mln-114
EV / EBITDA-15.51
EV / EBIT-15.33

Quote Details

Last 52.31
Change 2.61 (5.25%)
Open 49.11
Volume 902,499
Turnover 47,209,724
Average Volume 694,397

Financial Ratios

Leverage Ratio1.13
Current Ratio9.16
Price / Book10.84
Price / Tangible Book10.84
Debt / Equity0.03

Financial Strength

1-Year Target Price74.75
Short Ratio6.01

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 12.88% 94 / 100   
1 Month 53.63% 99 / 100   
2 Months 11.42% 88 / 100   
6 Months 194% 100 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog